Myrio Tx
Myrio Therapeutics (formerly Affinity BIO) is revolutionizing the field of immuno-oncology by enabling antibody-based therapies to attack targets that are inside cells.
Launch date
Employees
Company register number 140599800
Melbourne Victoria (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
AUD500k | Grant | ||
N/A | Grant | ||
| Total Funding | AUD500k | ||
Related Content
Recent News about Myrio Tx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.